sEphB4-HSA

DRUG2 trials

Sponsors

Vasgene Therapeutics, Inc

Conditions

Kaposi SarcomaMetastatic Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma

Phase 2

A Study of sEphB4-HSA in Kaposi Sarcoma

RecruitingNCT03993106

Vasgene Therapeutics, IncKaposi Sarcoma

Start: 2020-09-17End: 2025-06-30Target: 65Updated: 2024-05-02

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

RecruitingNCT06493552

Vasgene Therapeutics, IncMetastatic Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma

Start: 2025-03-15End: 2034-08-31Target: 700Updated: 2025-04-03